Osang Healthcare Co.,Ltd (KOSDAQ:036220)
South Korea
· Delayed Price · Currency is KRW
9,990.00
-330.00 (-3.20%)
Mar 9, 2026, 3:30 PM KST
Osang Healthcare Co.,Ltd Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 137,371 | 156,175 | - | - | - | - | |
| Market Cap Growth | -35.94% | - | - | - | - | - | |
| Enterprise Value | 128,108 | 129,560 | - | - | - | - | |
| Last Close Price | 9990.00 | 11390.00 | - | - | - | - | |
| PE Ratio | 27.03 | - | - | - | - | - | |
| PS Ratio | 1.15 | 1.94 | - | - | - | - | |
| PB Ratio | 0.49 | 0.55 | - | - | - | - | |
| P/TBV Ratio | 0.50 | 0.56 | - | - | - | - | |
| P/FCF Ratio | 89.42 | - | - | - | - | - | |
| P/OCF Ratio | 11.53 | - | - | - | - | - | |
| EV/Sales Ratio | 1.08 | 1.61 | - | - | - | - | |
| EV/EBITDA Ratio | 17.67 | - | - | - | - | - | |
| EV/FCF Ratio | 83.39 | - | - | - | - | - | |
| Debt / Equity Ratio | 0.17 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | |
| Debt / EBITDA Ratio | 9.37 | - | 0.00 | 0.01 | - | 0.01 | |
| Debt / FCF Ratio | 30.68 | - | 0.01 | 0.02 | 0.34 | 0.02 | |
| Net Debt / Equity Ratio | -0.03 | -0.03 | -0.49 | -0.30 | -0.26 | -0.34 | |
| Net Debt / EBITDA Ratio | -1.89 | 0.54 | -0.96 | -1.10 | 14.79 | -0.41 | |
| Net Debt / FCF Ratio | -6.20 | 0.14 | -1.22 | -1.97 | -26.35 | -0.72 | |
| Asset Turnover | 0.38 | 0.26 | 1.25 | 0.88 | 0.61 | - | |
| Inventory Turnover | 3.05 | 2.87 | 4.65 | 2.95 | 2.72 | - | |
| Quick Ratio | 5.60 | 4.41 | 6.27 | 2.19 | 7.14 | 2.55 | |
| Current Ratio | 7.12 | 7.49 | 6.90 | 3.22 | 10.82 | 3.99 | |
| Return on Equity (ROE) | 1.89% | -3.93% | 47.31% | 21.49% | 0.78% | - | |
| Return on Assets (ROA) | -0.51% | -4.99% | 31.23% | 14.04% | -2.05% | - | |
| Return on Invested Capital (ROIC) | -0.91% | -11.51% | 75.20% | 28.47% | -5.41% | 132.69% | |
| Return on Capital Employed (ROCE) | -0.80% | -8.60% | 48.50% | 24.60% | -4.00% | 81.10% | |
| Earnings Yield | 3.85% | -7.28% | - | - | - | - | |
| FCF Yield | 1.12% | -42.63% | - | - | - | - | |
| Dividend Yield | 4.84% | 4.39% | - | - | - | - | |
| Payout Ratio | 129.50% | - | 21.77% | 61.25% | 1679.92% | - | |
| Buyback Yield / Dilution | -12.58% | -3.97% | -1.69% | -4.37% | 7.21% | -67.60% | |
| Total Shareholder Return | -7.73% | 0.42% | -1.69% | -4.37% | 7.21% | -67.60% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.